--Indonesian drug maker PT Kalbe Farma is weighing an initial public offering for its nutritional food unit PT Sanghiang Perkasa on the Jakarta stock exchange, which could raise up to $500 million, Bloomberg reports, citing people familiar with the matter.
--Kalbe Farma has chosen advisers for the planned IPO and aims to list the unit this year, Bloomberg said.
Full story: https://bloom.bg/2ErzsWu
Write to Singapore editors at singaporeeditors@dowjones.com